Ethan Basch

Ethan Basch

UNVERIFIED PROFILE

Are you Ethan Basch?   Register this Author

Register author
Ethan Basch

Ethan Basch

Publications by authors named "Ethan Basch"

Are you Ethan Basch?   Register this Author

100Publications

2233Reads

48Profile Views

Stakeholder perspectives on addressing adverse events from adjuvant cancer therapy: A qualitative study.

Cancer 2019 Aug 27. Epub 2019 Aug 27.

Health Policy and Management, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32448DOI Listing
August 2019

Association Between Reimbursement Incentives and Physician Practice in Oncology: A Systematic Review.

JAMA Oncol 2019 Jun;5(6):893-899

Department of Health Policy and Management, University of North Carolina Gillings School of Global Public Health, Chapel Hill.

View Article

Download full-text PDF

Source
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaoncol.2018.6196DOI Listing
June 2019

Cost-Effectiveness of Web-Based Patient-Reported Outcome Surveillance in Patients With Lung Cancer.

J Thorac Oncol 2019 Jun 15;14(6):1012-1020. Epub 2019 Feb 15.

Department of Radiation Oncology, Jean Bernard Center, Inter-Regional Institute of Oncology, Le Mans, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.02.005DOI Listing
June 2019

Commentary on King-Kallimanis et al.: Inadequate measurement of symptomatic adverse events in immunotherapy registration trials.

Clin Trials 2019 Jun 21;16(3):327-328. Epub 2019 Mar 21.

3 Division of Pediatric Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1740774519836989
Publisher Site
http://dx.doi.org/10.1177/1740774519836989DOI Listing
June 2019

High Compliance Rates With Patient-Reported Outcomes in Oncology Trials Submitted to the US Food and Drug Administration.

Authors:
Ethan Basch

J Natl Cancer Inst 2019 May;111(5):437-439

Lineberger Comprehensive Cancer Center and Division of Hematology-Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy183DOI Listing
May 2019

Older Adults with Cancer: A Randomized Controlled Trial of Occupational and Physical Therapy.

J Am Geriatr Soc 2019 May;67(5):953-960

Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgs.15930DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494097PMC
May 2019

Reporting standards for patient-reported outcomes in clinical trial protocols and publications.

J Natl Cancer Inst 2019 Apr 11. Epub 2019 Apr 11.

Division of Oncology, Children's Hospital of Philadelphia, Philadelphia , PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djz047DOI Listing
April 2019

The Evolving Uses of "Real-World" Data.

JAMA 2019 04;321(14):1359-1360

Associate Editor.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2019.4064DOI Listing
April 2019

Patient-reported outcome monitoring in a routine paediatric oncology setting: challenges and opportunities.

Lancet Oncol 2019 Jan;20(1):19-20

Centre for Patient Reported Outcome Research, Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK; National Institute for Health Research Birmingham Biomedical Research Centre and National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30785-XDOI Listing
January 2019

Oncology in Transition: Changes, Challenges, and Opportunities.

JAMA 2018 12;320(21):2203-2204

University of North Carolina Cancer Center, Chapel Hill.

View Article

Download full-text PDF

Source
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.20
Publisher Site
http://dx.doi.org/10.1001/jama.2018.17057DOI Listing
December 2018

Application of a Bayesian graded response model to characterize areas of disagreement between clinician and patient grading of symptomatic adverse events.

J Patient Rep Outcomes 2018 Dec 4;2(1):56. Epub 2018 Dec 4.

Department of Psychiatry & Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave., 7th Floor, New York, NY, 10022, USA.

View Article

Download full-text PDF

Source
https://jpro.springeropen.com/articles/10.1186/s41687-018-00
Publisher Site
http://dx.doi.org/10.1186/s41687-018-0086-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279753PMC
December 2018

Sorafenib for Advanced and Refractory Desmoid Tumors.

N Engl J Med 2018 12;379(25):2417-2428

From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center (M.M.G., W.D.T., N.H., N.P.A., R.A.L., Y.M., R.Y.) and Columbia University Vagellos College of Physicians and Surgeons and New York Presbyterian Hospital (L.H.S., G.K.S.), New York, and Northwell Cancer Institute and Cold Spring Harbor Laboratory, Lake Success (R.G.M.) - all in New York; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN (M.R.M.); Washington University School of Medicine, St. Louis (B.A.V.T.); M.D. Anderson Cancer Center, University of Texas, Houston (V.R.); Mayo Clinic in Florida, Jacksonville (S.A.); Yale University, New Haven, CT (H.A.D.); University Health Network Princess Margaret Cancer Centre, Toronto (A.A.G.); University of Iowa-Holden Comprehensive Cancer Center, Iowa City (M.M.M.); University of Alabama at Birmingham Cancer Center, Birmingham (R.M.C.); Fox Chase Cancer Center, Philadelphia (S.M.); Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC (M.J.P.); Duke Cancer Institute, Duke University Medical Center, Durham (R.F.R.), and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill (E.B.) - both in North Carolina; Dayton National Cancer Institute Community Oncology Research Program, Dayton, OH (T.S.); National Cancer Institute, Bethesda, MD (J.J.W.); and the Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ (A.C.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1805052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447029PMC
December 2018

Cabozantinib for Progressive Metastatic Castration-resistant Prostate Cancer Following Docetaxel: Combined Analysis of Two Phase 3 Trials.

Eur Urol Oncol 2018 Nov 30. Epub 2018 Nov 30.

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2018.11.006DOI Listing
November 2018

Pharmaceutical assistance programs for cancer patients in the era of orally administered chemotherapeutics.

J Oncol Pharm Pract 2018 Sep 17;24(6):424-432. Epub 2017 Jul 17.

1 Department of Hematology/Oncology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155217719585DOI Listing
September 2018

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048.

J Clin Oncol 2018 Sep 11:JCO2018788620. Epub 2018 Sep 11.

Ethan Basch, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Bryce B. Reeve, Duke Cancer Institute, Duke University Medical Center, Durham, NC; Ethan Basch, Lauren J. Rogak, Mary C. Shaw, Narre Heon, and Martin R. Weiser, Memorial Sloan Kettering Cancer Center, New York, NY; Amylou C. Dueck and Brenda Ginos, Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ; Sandra A. Mitchell, Lori M. Minasian, and Andrea M. Denicoff, National Cancer Institute, Rockville, MD; Jennifer K. Wind, Harvey J. Mamon, and Deborah Schrag, Dana-Farber/Partners CancerCare, Boston, MA; Qian Shi, Garth D. Nelson, and Jeffrey P. Meyers, Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; George J. Chang, University of Texas MD Anderson Cancer Center, Houston, TX; Tatjana Kolevska, Kaiser Permanente Vallejo Medical Center, Vallejo, CA; and Deborah Watkins Bruner, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.8620DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209091PMC
September 2018

Relationship between sleep and exercise as colorectal cancer survivors transition off treatment.

Support Care Cancer 2018 Aug 22;26(8):2663-2673. Epub 2018 Feb 22.

Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4110-8DOI Listing
August 2018

Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

J Clin Oncol 2018 05 2;36(15):1521-1539. Epub 2018 Apr 2.

Michael J. Morris and Dana Rathkopf, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, NY; R. Bryan Rumble, American Society of Clinical Oncology, Alexandria, VA; Ethan Basch and Matthew I. Milowsky, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Sebastien J. Hotte, Juravinski Cancer Centre, Hamilton; Andrew Loblaw, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; Paul Celano, Greater Baltimore Medical Center, Towson, MD; and Rick Bangs, patient representative.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.0619DOI Listing
May 2018

Patient-reported outcomes: an essential component of oncology drug development and regulatory review.

Authors:
Ethan Basch

Lancet Oncol 2018 05;19(5):595-597

Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, 27599 NC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30141-4DOI Listing
May 2018

Implementation of Patient-Reported Outcomes in Routine Medical Care.

Am Soc Clin Oncol Educ Book 2018 May;38:122-134

From the UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Odette Cancer Centre, University of Toronto, Toronto, ON, Canada; Geisel School of Medicine, Dartmouth College, Hanover, NH; University of Leeds, Leeds, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_200383DOI Listing
May 2018

Symptom Monitoring in Pediatric Oncology Using Patient-Reported Outcomes: Why, How, and Where Next.

Patient 2018 04;11(2):147-153

Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40271-017-0279-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845473PMC
April 2018

Spending by Commercial Insurers on Chemotherapy Based on Site of Care, 2004-2014.

JAMA Oncol 2018 Apr;4(4):580-581

University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.5544DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885220PMC
April 2018

Sleep quality in individuals diagnosed with colorectal cancer: Factors associated with sleep disturbance as patients transition off treatment.

Psychooncology 2018 03 19;27(3):1050-1056. Epub 2017 Dec 19.

Department of Population Health Sciences, Duke School of Medicine, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.4595DOI Listing
March 2018

Strategies to Achieve High-Value Oncology Care-A Beginning.

JAMA Oncol 2018 02;4(2):171-172

Institute for Healthcare Improvement, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.3794DOI Listing
February 2018

The Oncology Care Model: Perspectives From the Centers for Medicare & Medicaid Services and Participating Oncology Practices in Academia and the Community.

Am Soc Clin Oncol Educ Book 2017 ;37:460-466

From the Centers for Medicare & Medicaid Services, Washington, DC; Smilow Cancer Hospital at Yale-New Haven, Yale Cancer Center, New Haven, CT; Hematology Oncology Associates of Central New York, East Syracuse, NY; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_174909DOI Listing
December 2017

Patient-Reported Symptom Monitoring During Chemotherapy-Reply.

JAMA 2017 11;318(19):1935-1936

Mayo Clinic, Scottsdale, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2017.14903DOI Listing
November 2017

The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice.

Qual Life Res 2017 10 29;26(10):2763-2772. Epub 2017 Jun 29.

Department of Health Policy and Management, University of North Carolina, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11136-017-1635-0DOI Listing
October 2017

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update.

J Clin Oncol 2017 Oct 31;35(28):3240-3261. Epub 2017 Jul 31.

Paul J. Hesketh, Lahey Hospital and Medical Center, Burlington; Kimberly Noonan, Dana-Farber Cancer Institute, Boston, MA; Mark G. Kris, Memorial Sloan Kettering Cancer Center, New York, NY; Ethan Basch and Stacie B. Dusetzina, University of North Carolina at Chapel Hill, Chapel Hill; Sally Y. Barbour, Duke University Medical Center, Durham, NC; Kari Bohlke and Mark R. Somerfield, American Society of Clinical Oncology, Alexandria; Michael A. Danso, Virginia Oncology Associates, Virginia Beach; Michael A. Danso, Virginia Oncology Associates, Norfolk, VA; Rebecca Anne Clark-Snow, University of Kansas Cancer Center, Westwood, KS; Cathy Eng, The University of Texas MD Anderson Cancer Center, Houston, TX; Dee Sparacio, Patient Representative, Hightstown, NJ; Gary H. Lyman, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA; Kristopher Dennis, The Ottawa Hospital and University of Ottawa, Ottawa; L. Lee Dupuis, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; Petra C. Feyer, Vivantes Clinics Neukoelln, Berlin; and Karin Jordan, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.4789DOI Listing
October 2017

Role of Patient-Reported Outcomes in Postsurgical Monitoring in Oncology.

J Oncol Pract 2017 08 6;13(8):535-538. Epub 2017 Jul 6.

University of North Carolina at Chapel Hill and Lineberger Comprehensive Cancer Center, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.023838DOI Listing
August 2017

Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy.

Int J Radiat Oncol Biol Phys 2017 07 2;98(4):850-857. Epub 2016 Dec 2.

Department of Radiation Oncology, University of North Carolina at Chapel Hill/Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.11.048DOI Listing
July 2017

Trustworthiness of Patient-Reported Outcomes in Unblinded Cancer Clinical Trials.

JAMA Oncol 2017 06;3(6):738-739

Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill4Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.3328DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362349PMC
June 2017

Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion.

J Clin Oncol 2017 Jun 25;35(17):1952-1964. Epub 2017 Apr 25.

Katherine S. Virgo, Emory University, Atlanta, GA; Ethan Basch, University of North Carolina, Chapel Hill, NC; D. Andrew Loblaw, Sunnybrook Health Sciences Centre, Toronto; Eric Winquist, London Health Sciences Centre, London, Ontario, Canada; Thomas K. Oliver and R. Bryan Rumble, American Society of Clinical Oncology, Alexandria, VA; Michael A. Carducci, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Luke Nordquist, Urology Cancer Center and GU Research Network, Omaha, NE; Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston, MA; and Eric A. Singer, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.8030DOI Listing
June 2017

Evaluating Alternative Payment Models in Oncology.

Authors:
Ethan Basch

JAMA 2017 05;317(20):2123-2124

Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill2Associate Editor, JAMA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2017.3028DOI Listing
May 2017

Cognitive Interview-Based Validation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Adolescents with Cancer.

J Pain Symptom Manage 2017 04 3;53(4):759-766. Epub 2017 Jan 3.

Department of Nursing Research and Quality Outcomes, Children's National Health System, Washington, District of Columbia, USA; Department of Pediatrics, George Washington University, Washington, District of Columbia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2016.11.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374011PMC
April 2017

Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting.

J Cancer Res Clin Oncol 2017 Apr 16;143(4):735-743. Epub 2017 Jan 16.

Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave., 7th Floor, New York, NY, 10022, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-016-2335-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354957PMC
April 2017

Appropriate Use of Antiemetics to Prevent Chemotherapy-Induced Nausea and Vomiting.

JAMA Oncol 2017 03;3(3):307-309

Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.2616DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558447PMC
March 2017

The Potential Role of Symptom Questionnaires in Palliative and Supportive Cancer Care Delivery.

Curr Oncol Rep 2017 Feb;19(2):12

Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0571-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508513PMC
February 2017

From Intuition to Execution: Realizing the Potential of Wearables in Oncology.

J Oncol Pract 2017 02;13(2):90-92

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.020370DOI Listing
February 2017

Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Am Soc Clin Oncol Educ Book 2016 ;35:67-73

From the Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD; Independent Cancer Patient Advocate, Los Angeles, CA; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Outcomes Research Branch, National Cancer Institute, Rockville, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_159514DOI Listing
January 2017

Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update.

J Clin Oncol 2017 Jan 28;35(1):96-112. Epub 2016 Oct 28.

Betty R. Ferrell, City of Hope Medical Center, Duarte, CA; Jennifer S. Temel and Jeffrey M. Peppercorn, Massachusetts General Hospital; Tracy A. Balboni, Dana-Farber Cancer Institute, Boston, MA; Sarah Temin, American Society of Clinical Oncology, Alexandria; Erin R. Alesi, Virginia Commonwealth University Health System, Richmond, VA; Ethan M. Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Janice I. Firn, University of Michigan Health System, Ann Arbor, MI; Judith A. Paice, Northwestern University, Evanston, IL; Tanyanika Phillips, CHRISTUS St Frances Cabrini Hospital, Alexandria, LA; Ellen L. Stovall, National Coalition for Cancer Survivorship, Silver Spring; Thomas J. Smith, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD; and Camilla Zimmermann, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.1474DOI Listing
January 2017

Patient-Reported Outcomes - Harnessing Patients' Voices to Improve Clinical Care.

Authors:
Ethan Basch

N Engl J Med 2017 Jan;376(2):105-108

From the Outcomes Research Program, Lineberger Comprehensive Cancer Center, Department of Medicine, University of North Carolina, Chapel Hill.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp1611252DOI Listing
January 2017

Translating Cancer Surveillance Data Into Effective Public Health Interventions.

JAMA 2017 01;317(4):365-367

Associate Editor, JAMA3Cancer Outcomes Research Program, University of North Carolina at Chapel Hill.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2016.20326DOI Listing
January 2017

Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors.

JAMA Oncol 2016 Dec;2(12):1628-1631

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill3UNC Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, University of North Carolina at Chapel Hill, Chapel Hill4Gillings School of Global Public Health, Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill5Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.2710DOI Listing
December 2016

Examining racial variation in antiemetic use and post-chemotherapy health care utilization for nausea and vomiting among breast cancer patients.

Support Care Cancer 2016 12 27;24(12):4839-4847. Epub 2016 Jul 27.

Department of Health Policy and Management, , CB#7411, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-016-3338-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507660PMC
December 2016

All together now: findings from a PCORI workshop to align patient-reported outcomes in the electronic health record.

J Comp Eff Res 2016 11 2;5(6):561-567. Epub 2016 Sep 2.

Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cer-2016-0026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549656PMC
November 2016

It's a long shot, but it just might work! Perspectives on the future of medicine.

BMC Med 2016 Nov 7;14(1):176. Epub 2016 Nov 7.

Oxford University Hospitals NHS Trust, 18 Middle Way, Oxford, OX2 7LG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12916-016-0727-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098283PMC
November 2016

Statewide geographic variation in outcomes for adults with acute myeloid leukemia in North Carolina.

Cancer 2016 10 28;122(19):3041-50. Epub 2016 Jun 28.

Division of Hematology/Oncology, University of North Carolina, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30139DOI Listing
October 2016

Implementation of Symptom Questionnaires Into Oncology Workflow.

J Oncol Pract 2016 10;12(10):859-862

University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.015610DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508563PMC
October 2016

Leveraging Emerging Technologies and the "Internet of Things" to Improve the Quality of Cancer Care.

J Oncol Pract 2016 10 30;12(10):863-866. Epub 2016 Sep 30.

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; Carolina Health Informatics Program, Chapel Hill, NC; Lombardi Comprehensive Cancer Center; and Georgetown University, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.015784DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063188PMC
October 2016

Time to Reassess the Cancer Compendia for Off-label Drug Coverage in Oncology.

JAMA 2016 Oct;316(15):1541-1542

Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill2Associate Editor, JAMA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2016.12770DOI Listing
October 2016

Reply to K. Kroenke et al.

Authors:
Ethan Basch

J Clin Oncol 2016 09 18;34(27):3352. Epub 2016 Jul 18.

University of North Carolina, Chapel Hill, NC

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.9480DOI Listing
September 2016

Danish Translation and Linguistic Validation of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

J Pain Symptom Manage 2016 08 15;52(2):292-7. Epub 2016 Apr 15.

Unit of Survivorship, Danish Cancer Society, Copenhagen, Denmark; Department of Oncology, The Finsen Centre, Rigshospitalet, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2016.02.008DOI Listing
August 2016

The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review.

Support Care Cancer 2016 08 3;24(8):3669-76. Epub 2016 Jun 3.

Department of Psychiatry & Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave., 7th Floor, New York, NY, 10022, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-016-3297-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919215PMC
August 2016

Patient-reported outcome measurement in drug discovery: a tool to improve accuracy and completeness of efficacy and safety data.

Expert Opin Drug Discov 2016 Aug 16;11(8):753-8. Epub 2016 Jun 16.

b Department of Health Sciences Research , Mayo Clinic , Scottsdale , AZ , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17460441.2016.1193148DOI Listing
August 2016

Linguistic validation of the Spanish version of the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Support Care Cancer 2016 07 2;24(7):2843-51. Epub 2016 Feb 2.

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 485 Lexington Avenue, 2nd Floor, New York, NY, 10017, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-015-3062-5DOI Listing
July 2016

Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas.

J Thorac Oncol 2016 06 8;11(6):890-9. Epub 2016 Mar 8.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.02.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877255PMC
June 2016

Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.

JAMA Otolaryngol Head Neck Surg 2016 06;142(6):517-23

Department of Radiation Oncology, University of North Carolina, Chapel Hill4Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoto.2016.0656DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928525PMC
June 2016

Clinical Benefits Associated With Medicaid Coverage Before Diagnosis of Gynecologic Cancers.

J Oncol Pract 2016 06 31;12(6):e724-33. Epub 2016 May 31.

University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.011080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957260PMC
June 2016

Patient-reported outcomes in the evaluation of toxicity of anticancer treatments.

Nat Rev Clin Oncol 2016 May 20;13(5):319-25. Epub 2016 Jan 20.

Clinical Trials Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori - Fondazione G. Pascale IRCCS, via Mariano Semmola, 80131 Napoli, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2015.222DOI Listing
May 2016

Toward a Patient-Centered Value Framework in Oncology.

Authors:
Ethan Basch

JAMA 2016 May;315(19):2073-4

Cancer Outcomes Research Program, Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina, Chapel Hill2Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina, Chap.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2016.4637DOI Listing
May 2016

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.

J Clin Oncol 2016 Apr 22;34(12):1402-18. Epub 2016 Feb 22.

Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College; David Nanus, NewYork Presbyterian Weill Cornell Medical Center; Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY; Walter M. Stadler, University of Chicago Medicine, Chicago, IL; Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA; Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC; Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD; Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX; Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA; Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC; Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit; and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA; Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI; Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ; Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Oliver Sartor, Tulane School of Medicine, New Orleans, LA; Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School; Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.2702DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872347PMC
April 2016

Investigating racial disparities in use of NK1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among women with breast cancer.

Breast Cancer Res Treat 2016 Apr 11;156(2):351-9. Epub 2016 Mar 11.

Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, CB#7411, Chapel Hill, NC, 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3747-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820391PMC
April 2016

Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials.

Clin Ther 2016 04 2;38(4):821-30. Epub 2016 Apr 2.

Section of Biostatistics, Mayo Clinic, Scottsdale, Arizona. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2016.03.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851916PMC
April 2016

Repeated measures analysis of patient-reported outcomes in prostate cancer after abiraterone acetate.

J Community Support Oncol 2016 Apr;14(4):148-54

Departmnet of Medicine, The University of North Carolina at Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12788/jcso.0246DOI Listing
April 2016